SEC Form 4 · accession 0001209191-17-044735
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Benjamin Guzman
Officer — Sr.VP Corp. Strategy & Finance
Period of report
Jul 7, 2017
Accepted (ET)
Jul 11, 2017 · 12:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $4.78 | Jul 7, 2017 | A | 300,000 | A | Jul 7, 2018 | Jul 7, 2027 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The Options vest in 3 equal annual installments beginning on the first annual anniversary of the Grant Date (July 7, 2017).